Clik here to view.
ProQuad (measles/mumps/rubella/varicella vaccine, live)
Updated monograph to reflect current availability status; vaccine will be unavailable through the remainder of 2007. Learn more at www.epocrates.com
View ArticleClik here to view.
ceftriaxone (Rocephin, generic)
Updated monographs based on recent MedWatch Safety Alert regarding revisions to ceftriaxone prescribing information; revisions include new information on the risk associated with concomitant use of...
View ArticleClik here to view.
Omacor (omega-3-acid ethyl esters)
Used for the treatment of hypertriglyceridemia, has been confused with Amicar (aminocaproic acid), a drug used to treat excessive bleeding from fibrinolysis, in part because both are available in 1 g...
View ArticleRevised ACIP Recommendations for Meningococcal Vaccination
The Advisory Committee on Immunization Practices (ACIP) recently revised their recommendations to include routine vaccination of all individuals 11-18 years of age with one dose of the meningococcal...
View ArticleNew Black Box Warnings for Thiazolidinediones
The FDA has determined that the thiazolidinedione class of anti-diabetics needed updated labeling with a boxed warning emphasizing the risk of heart failure. Patients should be observed carefully for...
View ArticleClik here to view.
Additional indications for Risperdal in Children and Adolescents
The FDA has approved the use of Risperdal (risperidone) for the treatment of schizophrenia in adolescents aged 13-17 years old and for the treatment of acute manic or mixed episodes associated with...
View ArticleClik here to view.
New Drug Monograph for Bendroflumethiazide/Nadolol
The FDA has approved first-time generic formulations for bendroflumethiazide/nadolol for the treatment of hypertension in adult patients. Bendroflumethiazide/nadolol is equivalent to Corzide. Learn...
View ArticleClik here to view.
New Drug Monograph for Carvedilol
The FDA has approved first-time generic formulations for carvedilol. Carvedilol is equivalent to Coreg, which is indicated for the treatment of hypertension, chronic heart failure, and left ventricular...
View ArticleClik here to view.
Additional Indications for Short Course Levaquin Therapy
The FDA has approved Levaquin 750 mg as a 5-day, once daily regimen for the treatment of complicated urinary tract infection and acute pyelonephritis. Learn more at www.epocrates.com
View ArticleClik here to view.
New Lower Strength of Soma Approved
The FDA has approved a 250 mg strength of Soma (carisoprodol) for the relief of discomfort associated with acute, painful musculoskeletal conditions. Learn more at www.epocrates.com
View ArticleClik here to view.
New Drug Monograph for Xyzal
The FDA has approved Xyzal (levocetirizine) for the symptomatic relief of seasonal and perennial allergic rhinitis and for the treatment of uncomplicated skin manifestations of chronic idiopathic...
View ArticleClik here to view.
New Vaccine Monograph for Afluria
The FDA has approved Afluria, a new influenza vaccine, for active immunization against influenza virus subtypes A and type B in individuals >18 years of age for the 2007-2008 flu season. Learn more...
View ArticleClik here to view.
Epocrates ID Update
The following sections of Epocrates ID have recently been reviewed and revised: CNS, ENT, Genital, Lung, Other, Skin/Soft Tissue, Systemic, and Urinary Tract. Furthermore, there are new additions to...
View ArticleClik here to view.
IV Compatibility Information
The IV compatibility information in Epocrates Rx has recently been updated. Additions include 3 new drugs (aripiprazole, caspofungin, and ropivacaine) in the IV compatability checker and new...
View ArticleClik here to view.
Reports of Acute Pancreatitis with Byetta Use
The FDA has reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta (exenatide), and an association between Byetta and acute pancreatitis is suspected. Byetta is indicated for...
View ArticleClik here to view.
New Warnings for Provigil
The prescribing information for Provigil (modafinil) has recently been revised to include warnings on serious rash, including Stevens-Johnson Syndrome, hypersensitivity reactions, and psychiatric...
View ArticleClik here to view.
Trasylol Withdrawn from US Market
The FDA has announced that the marketing for Trasylol (aprotinin) has been suspended pending a review of preliminary results from the Canadian study suggesting an increased risk of death. Trasylol was...
View ArticleClik here to view.
Zyrtec-D Approved for OTC Use
The FDA has approved Zyrtec-D (cetirizine/pseudoephedrine) for nonprescription use for the relief of symptoms due to hay fever or other respiratory allergies, for reducing swelling of nasal passages,...
View ArticleClik here to view.
Additional Black Box Warning for Avandia
The black box warning for Avandia has been updated to include new information on the potential increased risk of myocardial ischemic events. While available data are inconclusive at this time,...
View ArticleClik here to view.
Updated Black Box Warnings for Erythropoiesis-Stimulating Agents
The FDA has recently approved revised labeling for Aranesp, Epogen, and Procrit, erythropoiesis-stimulating agents (ESA) used to treat certain types of anemia. The updated black box warnings discuss...
View Article
/fit-in/580x348/filters:format(webp)/english-betterindia/media/media_files/2026/09/17/balaghat-4-2026-09-17-19-01-31.png)
